# Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma

> **NCT04805203** · NA · TERMINATED · sponsor: **Intergroupe Francophone du Myelome** · enrollment: 139 (actual)

## Conditions studied

- Multiple Myeloma
- Covid19

## Interventions

- **OTHER:** blood sample analyses

## Key facts

- **NCT ID:** NCT04805203
- **Lead sponsor:** Intergroupe Francophone du Myelome
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-12-16
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 139 (ACTUAL)
- **Why stopped:** Recruitment delay due to difficulties to involve patient at Covid diagnosis in hematology departments Abandoned study
- **Last updated:** 2023-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04805203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04805203, "Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04805203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*